CHIKV infection results in MCP-induced cellular infiltration inside the inflamed joints, and bone loss may be ameliorated by treatment with an MCP-inhibiting drug, bindarit. Taken together, our data expose a Formerly undescribed position for MCPs in CHIKV-induced bone loss: among recruiting monocytes/OC precursors to joint websites and thus favoring a https://kateq000kwi5.wikilinksnews.com/user